Last update 29 Mar 2026

Enoch Pharmaceutical (Guangdong) Co., Ltd

Subsidiary Company|2023|Guangdong Sheng, China

Overview

Tags

Digestive System Disorders
Neoplasms
Skin and Musculoskeletal Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Immune System Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug4
Top 5 TargetCount
TNF-α(Tumor necrosis factor α)1
PDL1(Programmed death-ligand 1)1
NOX4(NADPH oxidase 4)1

Related

4
Drugs associated with Enoch Pharmaceutical (Guangdong) Co., Ltd
S-propargyl-cysteine
Target-
Mechanism-
Active Org.
Enoch Pharmaceutical (Guangdong) Co., Ltd [+1]
Originator Org.
Fudan UniversityFudan University
Active Indication
Rheumatoid Arthritis
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
Leonurine Sulfate
Target
NOX4
Mechanism
NOX4 modulators
Active Org.
Zhuhai Hengqin New Area Zhongzhu Zhengtai Med Mgmt Co., Ltd.Zhuhai Hengqin New Area Zhongzhu Zhengtai Med Mgmt Co., Ltd. [+2]
Originator Org.
Zhuhai Hengqin New Area Zhongzhu Zhengtai Med Mgmt Co., Ltd.Zhuhai Hengqin New Area Zhongzhu Zhengtai Med Mgmt Co., Ltd.
Active Indication
Primary Hyperlipidemia
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
CN119775199
Patent Mining
Target
TNF-α
Mechanism-
Active Org.
Enoch Pharmaceutical (Guangdong) Co., Ltd [+1]
Originator Org.
Enoch Pharmaceutical (Guangdong) Co., Ltd [+1]
Active Indication
Digestive System Disorders [+1]
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Enoch Pharmaceutical (Guangdong) Co., Ltd
CTR20255251
/ Not yet recruitingPhase 1
评价口服炔丙基半胱氨酸胶囊在中国健康受试者中单次给药的安全性、耐受性、药代动力学特征的I期临床研究
[Translation] A Phase I clinical study evaluating the safety, tolerability, and pharmacokinetic characteristics of oral propargylcysteine capsules in healthy Chinese subjects after a single dose.
100 Clinical Results associated with Enoch Pharmaceutical (Guangdong) Co., Ltd
Login to view more data
0 Patents (Medical) associated with Enoch Pharmaceutical (Guangdong) Co., Ltd
Login to view more data
100 Deals associated with Enoch Pharmaceutical (Guangdong) Co., Ltd
Login to view more data
100 Translational Medicine associated with Enoch Pharmaceutical (Guangdong) Co., Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 06 Apr 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
2
1
IND Application
Phase 1
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
S-propargyl-cysteine
Rheumatoid Arthritis
More
Phase 1
CN119775199
 ( TNF-α )Patent Mining		Digestive System Disorders
More
Discovery
CN120647613
 ( PDL1 )Patent Mining		Neoplasms
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free